Rorschach is a gripping psychological thriller starring Mammootty as a man seeking answers after his wife's mysterious ...

HYPE rallies toward $50 after Sonnet BioTherapeutics combines with Rorschach to launch a $583 million Hyperliquid token ...

The Netherlands-based drum’n’bass producer’s dazzlingly kinetic EP flips the script, channeling unpredictable rhythms into ...

Psychological testing has evolved from Freud to AI and eye tracking. Technology adds depth, but theory and ethics must guide its use to ensure meaningful and equitable diagnoses.

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

At the closing of the transaction, the newly created combined entity will be named Hyperliquid Strategies Inc., which is ...

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a ...

Bitcoin (BTC) is leading crypto markets to uncharted territory as four crypto treasury companies announce the acquisition of ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...

European shares were mostly lower today. The eurozone's STOXX 600 dipped 0.26%, while Spain's IBEX 35 Index fell 0.05%.

Sonnet BioTherapeutics to merge with Rorschach I LLC in a $888 million deal, forming crypto-focused Hyperliquid Strategies ...

Sonnet BioTherapeutics is merging with Rorschach I LLC to form Hyperliquid Strategies in an $888M deal. The merger boosts HYPE token’s market momentum.